Latest filing published 29 Jun 2026 for Beam Therapeutics Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by FMR LLC span 38 companies, the busiest being ViewRay, Inc., REGENXBIO Inc. and Beam Therapeutics Inc. Between 6 July 2009 and 26 June 2026, the trades on record add up to 624 filings.
In open-market terms, that means 13 purchases worth €24.7M on one side and 433 sales worth €170.1M on the other. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: no purchases and 2 sales on the market.
The median purchase comes to €934k. On 3 out of 5 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
On 29 June 2026 came the latest disclosure, an open-market sale for €1.0M in Beam Therapeutics Inc. The last insider purchase was made public on 29 November 2023, 1,060 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 45 declarations